ZHEJIANG FDA Thursday, November 16, 2017 0.00 Neutral

FDA Approves Unknown Drug — ZHEJIANG HISUN PHARM

Zhejiang Hisun Pharm has received FDA approval for the generic version of S Combipres (ncludpril & clonidine) indicated for hypertension, securing a significant competitive foothold in the U.S. market and broadening the company's revenue streams.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

GET FREE KEY — 10,000 calls/day